We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · October 21, 2020

Poor Outcomes of Patients With Metastatic Cancer Receiving Immune Checkpoint Inhibitors as Inpatients

The Oncologist

 

Additional Info

Disclosure statements are available on the authors' profiles:

The Oncologist
Clinical Outcomes of Patients With Metastatic Cancer Receiving Immune Checkpoint Inhibitors in the Inpatient Setting
Oncologist 2020 Oct 12;[EPub Ahead of Print], SM Durbin, L Zubiri, A Niemierko, A Bardia, RJ Sullivan, C McEwen, TM Mulvey, IM Allen, DP Lawrence, JV Cohen, EP Hochberg, DP Ryan, LA Petrillo, KL Reynolds

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading